Abstract:Identification of regulatable mechanisms by which transcription factor NF-E2 p45-related factor 2 (Nrf2) is repressed will allow strategies to be designed that counter drug resistance associated with its upregulation in tumours that harbour somatic mutations in Kelch-like ECH-associated protein-1 (Keap1) , a gene that encodes a joint adaptor and substrate receptor for the Cul3–Rbx1/Roc1 ubiquitin ligase. We now show that mouse Nrf2 contains two binding sites for β-transducin repeat-containing protein (β-TrCP), which acts as a substrate receptor for the Skp1–Cul1–Rbx1/Roc1 ubiquitin ligase complex. Deletion of either binding site in Nrf2 decreased β-TrCP-mediated ubiquitylation of the transcription factor. The ability of one of the two β-TrCP-binding sites to serve as a degron could be both increased and decreased by manipulation of glycogen synthase kinase-3 (GSK-3) activity. Biotinylated-peptide pull-down assays identified DSGIS 338 and DSAPGS 378 as the two β-TrCP-binding motifs in Nrf2. Significantly, our pull-down assays indicated that β-TrCP binds a phosphorylated version of DSGIS more tightly than its non-phosphorylated counterpart, whereas this was not the case for DSAPGS. These data suggest that DSGIS, but not DSAPGS, contains a functional GSK-3 phosphorylation site. Activation of GSK-3 in Keap1-null mouse embryonic fibroblasts (MEFs), or in human lung A549 cells that contain mutant Keap1 , by inhibition of the phosphoinositide 3-kinase (PI3K)–protein kinase B (PKB)/Akt pathway markedly reduced endogenous Nrf2 protein and decreased to 10–50% of normal the levels of mRNA for prototypic Nrf2-regulated enzymes, including the glutamate-cysteine ligase catalytic and modifier subunits, glutathione S- transferases Alpha-1 and Mu-1, haem oxygenase-1 and NAD(P)H:quinone oxidoreductase-1. Pre-treatment of Keap1 −/− MEFs or A549 cells with the LY294002 PI3K inhibitor or the MK-2206 PKB/Akt inhibitor increased their sensitivity to acrolein, chlorambucil and cisplatin between 1.9-fold and 3.1-fold, and this was substantially attenuated by simultaneous pre-treatment with the GSK-3 inhibitor CT99021.

Sugar-mediated non-canonical ubiquitination impairs Nrf1/NFE2L1 activation

Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy.

Abstract 4061: Depleting the cellular level of glutathione and subsequently<i>S</i>-glutathionylation of keap1 by electrophilic agents activates keap1-nrf2 pathway

Abstract 4061: Depleting the cellular level of glutathione and subsequently S -glutathionylation of keap1 by electrophilic agents activates keap1-nrf2 pathway

UBE4A catalyzes NRF1 ubiquitination and facilitates DDI2-mediated NRF1 cleavage

Ubiquitin gets sweet: Sugar-mediated ubiquitination regulates Nrf1 function

Activation of the Membrane-Bound Nrf1 Transcription Factor by USP19, a Ubiquitin-Specific Protease C-terminally Anchored in the Endoplasmic Reticulum

A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction Between Keap1 and P62

Serine ubiquitination of SQSTM1 regulates NFE2L2-dependent redox homeostasis

UBE2G1 Governs the Destruction of Cereblon Neomorphic Substrates

Anything you can do, glycans do better: deglycosylation and noncanonical ubiquitination vie to rule the proteasome

Activating the NFE2L1-ubiquitin-proteasome system by DDI2 protects from ferroptosis

NHERF1 and NHERF2 Regulation of SR-B1 Stability Via Ubiquitination and Proteasome Degradation.

UBE2M is a Stress-Inducible Dual E2 for Neddylation and Ubiquitylation That Promotes Targeted Degradation of UBE2F.

UGGT1-mediated reglucosylation of N-glycan competes with ER-associated degradation of unstable and misfolded glycoproteins

SKN-1 Activation During Infection of C. elegans Requires CDC-48 and ER Proteostasis

Sag/Rbx2 is A Novel Substrate of Nedd4-1 E3 Ubiquitin Ligase and Mediates Nedd4-1 Induced Chemosensitization

Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity

ZNRF1 Mediates Epidermal Growth Factor Receptor Ubiquitination to Control Receptor Lysosomal Trafficking and Degradation

Structural basis of sugar recognition by SCFFBS2 ubiquitin ligase involved in NGLY1 deficiency

Dysfunction of the energy sensor NFE2L1 triggers uncontrollable AMPK signaling and glucose metabolism reprogramming